Revenue GrowthThe company's consistent revenue growth and operational efficiency highlight its ability to expand market presence and maintain competitive advantage.

Operational EfficiencyImproved gross profit margins demonstrate effective cost control, enhancing long-term profitability and competitiveness.

Cash Flow ImprovementEnhanced operating cash flow strengthens liquidity, providing flexibility for strategic investments and debt management.

Bears Say

Decline In Net Profit MarginA declining net profit margin can signal challenges in maintaining profitability, potentially impacting future earnings.

Low Free Cash FlowLow free cash flow limits the company's ability to reinvest in growth opportunities and manage debt effectively.

Increased LeverageRising leverage can increase financial risk, potentially affecting the company's ability to finance operations and growth.

Zim Laboratories Ltd. News

Zim Laboratories to Close Trading Window Ahead of December Quarter Results

Zim Laboratories Ltd. ( ($IN:ZIMLAB) ) just unveiled an update. Zim Laboratories Limited has announced the closure of...

2M ago

Zim Laboratories Confirms Regulatory Compliance for Q3 2025

An update from Zim Laboratories Ltd. ( ($IN:ZIMLAB) ) is now available. Zim Laboratories Limited has announced compliance...

5M ago

ZIMLAB FAQ

What was Zim Laboratories Ltd.’s price range in the past 12 months?

Zim Laboratories Ltd. lowest stock price was ₹64.10 and its highest was ₹126.95 in the past 12 months.

What is Zim Laboratories Ltd.’s market cap?

Zim Laboratories Ltd.’s market cap is ₹3.52B.

When is Zim Laboratories Ltd.’s upcoming earnings report date?

Zim Laboratories Ltd.’s upcoming earnings report date is May 14, 2026 which is in 81 days.

How were Zim Laboratories Ltd.’s earnings last quarter?

Zim Laboratories Ltd. released its earnings results on Feb 11, 2026. The company reported ₹0.902 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.902.

Is Zim Laboratories Ltd. overvalued?

According to Wall Street analysts Zim Laboratories Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Zim Laboratories Ltd. pay dividends?

Zim Laboratories Ltd. pays a Annually dividend of ₹0.167 which represents an annual dividend yield of N/A. See more information on Zim Laboratories Ltd. dividends here

What is Zim Laboratories Ltd.’s EPS estimate?

Zim Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zim Laboratories Ltd. have?

Zim Laboratories Ltd. has 48,735,813 shares outstanding.

What happened to Zim Laboratories Ltd.’s price movement after its last earnings report?

Zim Laboratories Ltd. reported an EPS of ₹0.902 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.719%.

Which hedge fund is a major shareholder of Zim Laboratories Ltd.?

Currently, no hedge funds are holding shares in IN:ZIMLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Zim Laboratories Ltd.

ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.